Page last updated: 2024-08-21

picolinamide and Angiogenesis, Pathologic

picolinamide has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, ZX; Lin, HJ; Luo, SD; Mao, YQ; Wang, Z; Wei, YQ; Xu, YZ; Yang, L; Yang, SY; Yu, LT; Zeng, XX; Zhao, YL; Zheng, RL; Zhou, LN; Zhou, Y1

Other Studies

1 other study(ies) available for picolinamide and Angiogenesis, Pathologic

ArticleYear
SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2011, Volume: 27, Issue:5

    Topics: Amides; Angiogenesis Inhibitors; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Collagen; Colorectal Neoplasms; Drug Combinations; Endothelial Cells; Female; Humans; Laminin; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Phosphorylation; Picolinic Acids; Protein Kinase Inhibitors; Proteoglycans; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Platelet-Derived Growth Factor; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish

2011